Integrated Metabolomic and Lipidomic Analysis Reveals the Neuroprotective Mechanisms of Bushen Tiansui Formula in an Aβ1-42-Induced Rat Model of Alzheimer’s Disease
Open Access
- 20 June 2020
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2020, 1-18
Abstract
Bushen Tiansui Formula (BSTSF) is a traditional Chinese medicine prescription. It has been widely applied to treat Alzheimer’s disease (AD) in the clinic; however, the mechanisms underlying its effects remain largely unknown. In this study, we used a rat AD model to study the effects of BSTSF on cognitive performance, and UPLC-MS/MS-based metabolomic and lipidomic analysis was further performed to identify significantly altered metabolites in the cerebral cortices of AD rats and determine the effects of BSTSF on the metabolomic and lipidomic profiles in the cerebral cortices of these animals. The results revealed that the levels of 47 metabolites and 30 lipids primarily associated with sphingolipid metabolism, glycerophospholipid metabolism, and linoleic acid metabolism were significantly changed in the cerebral cortices of AD rats. Among the altered lipids, ceramides, phosphatidylethanolamines, lysophosphatidylethanolamines, phosphatidylcholines, lysophosphatidylcholines, phosphatidylserines, sphingomyelins, and phosphatidylglycerols showed robust changes. Moreover, 34 differential endogenous metabolites and 21 lipids, of which the levels were mostly improved in the BSTSF treatment group, were identified as potential therapeutic targets of BSTSF against AD. Our results suggest that lipid metabolism is highly dysregulated in the cerebral cortices of AD rats, and BSTSF may exert its neuroprotective mechanisms by restoring metabolic balance, including that of sphingolipid metabolism, glycerophospholipid metabolism, alanine, aspartate, and glutamate metabolism, and D-glutamine and D-glutamate metabolism. Our data may lead to a deeper understanding of the AD-associated metabolic profile and shed new light on the mechanism underlying the therapeutic effects of BSTSF.Keywords
Funding Information
- Natural Science Foundation of Hunan Province (2017JJ3459, 2020JJ4803, 81673951, 81873169, 81603670)
- Natural Science Foundation of Hunan Province (2017JJ3459, 2020JJ4803, 81673951, 81873169, 81603670)
- National Natural Science Foundation of China (2017JJ3459, 2020JJ4803, 81673951, 81873169, 81603670)
- National Natural Science Foundation of China (2017JJ3459, 2020JJ4803, 81673951, 81873169, 81603670)
- National Natural Science Foundation of China (2017JJ3459, 2020JJ4803, 81673951, 81873169, 81603670)
This publication has 48 references indexed in Scilit:
- Brain Slices from Glutaminase-Deficient Mice Metabolize Less Glutamine: A Cellular Metabolomic Study with Carbon 13 NMRJournal of Cerebral Blood Flow & Metabolism, 2012
- Lipids in Alzheimer's disease: A century-old storyBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Accumulation of intraneuronal Aβ correlates with ApoE4 genotypeActa Neuropathologica, 2010
- DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 miceNeurobiology of Disease, 2009
- Biosynthesis, degradation and pharmacological importance of the fatty acid amidesDrug Discovery Today, 2008
- Principles of bioactive lipid signalling: lessons from sphingolipidsNature Reviews Molecular Cell Biology, 2008
- Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patientsNeurobiology of Aging, 2004
- Chemical Characterization of a Family of Brain Lipids That Induce SleepScience, 1995
- BrainN-acetyl-l-aspartic acid in Alzheimer's disease: a proton magnetic resonance spectroscopy studyBrain Research, 1994
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991